MarketInOut Stock Screener Log In | Sign Up

Drugs Made In America Acquisition Corp

NASDAQ • Financial Services • Shell Companies • Quote as of 10/27/2026 16:00
Drugs Made In America Acquisition Corp stock price and volume chart

Company Profile

IndustryShell Companies
SectorFinancial Services
ExchangeNASDAQ
Market Capitalization264.01 mln
Float18.56 mln
Earnings Date11/18/2026

EPS

0.18
Overpriced

P / E

60.39
Richly valued

Piotroski F-Score

3 / 9
Below average

Relative Strength

61 / 100
Outperforming

Debt / Equity

0.01
Debt-free

ROE

2.86
Very low

Business Description

Founded in 2024 and headquartered in Fort Lauderdale, Florida, Drugs Made In America Acquisition Corp. is a shell company created to find and complete a deal with an established business. The company is open to various transaction types, including mergers, asset purchases, and other arrangements that would bring an operating business under its umbrella.

Key Fundamentals

EPS0.18
P/E60.39
ROE2.86
ROIC-1.19
ROA2.76
EBITDA, mln6.09
EV / EBITDA54.91
EV / EBIT54.91

Quote Details

Last 10.87
Change -0.01 (-0.09%)
Open 10.87
Volume 6,923
Turnover 75,253
Average Volume 13,785

Financial Ratios

Leverage Ratio1.07
Current Ratio0.02
Price / Book1.92
Price / Tangible Book1.92
Debt / Equity0.01

Financial Strength

Piotroski F-Score 3 / 9
Price to Graham Number2.23
Short Ratio2.43
Short % of Float0.45

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 45 / 100   
1 Month 0.18% 58 / 100   
2 Months 2.16% 71 / 100   
6 Months 3.52% 64 / 100   
1 Year 6.05% 59 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog